LABMASTER RAISES €6M IN FUNDING

Labmaster Ltd, a Turku, Finland based biotechnology company raises €6M from a Korean
company for the development of next generation proprietary detection
technology.

Labmaster is developing new technology for clinical, biochemical and
chemical analysis based on cathodic electrochemiluminescence (CECL). This
technology relates to the electrical excitation of label
substance/substances by hot electrons. Reactions occur on silicon based
electrodes coated with an insulating layer and utilize the resulting
electrochemiluminescence in analytical applications, especially in
bioaffinity assays such as immunoassays and DNA-probe assays.

One of the advantages of this technology is cost effectiveness achieved by
replacing expensive optics with low priced sophisticated electronics. This
technology is suitable for many kinds of laboratory instrumentation
applications, for example in clinical diagnostics from batch size analyzers
to disposable rapid tests (POCT). Labmaster owns the immaterial property rights for
this technology and has the strategy to further protect its findings related
to new applications.


<< Back

Labmaster Oy | Fiskarsinkatu 11 | 20750 TURKU        Postal address Labmaster Oy (Ltd.) | Fiskarsinkatu 11 | 20750 TURKU, Finland     E-mail info@labmaster.fi       Copyright © Labmaster Ltd.

Labmaster Oy Fiskarsinkatu 11 | 20750 TURKU
Postal address Labmaster Oy (Ltd.) | Fiskarsinkatu 11 | 20750 TURKU, Finland
E-mail info@labmaster.fi
Copyright © Labmaster Ltd.

Labmaster Oy
Fiskarsinkatu 11
20750 TURKU

Postal address
Labmaster Oy (Ltd.)
Fiskarsinkatu 11
20750 TURKU
Finland

E-mail
info@labmaster.fi

Copyright
© Labmaster Ltd.